Consumers are feeling notably bad about where conditions are headed. That might be a good thing for investors.
Thermo Fisher Scientific targets $47.2B revenue and $24.80 EPS with 4% organic growth and Clario acquisition gains. Read why ...
Thermo Fisher Scientific (NYSE:TMO) said it delivered a “strong year” in 2025, closing with what management described as an ...
2d
Thermo Fisher Scientific Inc (TMO) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
Thermo Fisher Scientific Inc (TMO) reports robust financial performance with significant revenue growth and strategic ...
Reno market joins growing portfolio of customer-focused West Coast dealership RENO, CA, UNITED STATES, January 15, 2026 ...
3don MSN
Mariner review 2026
Mariner takes a hands-on approach to wealth management, but its high account minimums and fees might be limiting for some ...
Opportunities in the market include the rising demand due to increased clinical trials & biosimilar developments, especially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results